Viewing StudyNCT06487624



Ignite Creation Date: 2024-07-17 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06487624
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-06-24

Brief Title: An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein HCB301 in Subjects With Selected Advanced Tumors
Sponsor: FBD Biologics Limited
Organization: FBD Biologics Limited

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumor
Refractory Hodgkin Lymphoma
Keywords:
Name View
Immunotherapy View
CD47 View
PD-L1 View
TGF-beta View
Tumor View
Cancer View